Eledon Pharmaceuticals, Inc.
ELDN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36 | -$117 | -$88 | -$35 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | -$2 |
| Stock-Based Comp. | $13 | $7 | $8 | $0 |
| Change in WC | $9 | -$5 | $2 | -$0 |
| Other Non-Cash | -$34 | $75 | $49 | $8 |
| Operating Cash Flow | -$47 | -$40 | -$28 | -$29 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$156 | -$78 | $0 | $0 |
| Inv. Sales/Matur. | $86 | $33 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$70 | -$45 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $133 | $33 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $134 | $33 | $0 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $16 | -$52 | -$28 | -$29 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5 | $56 | $85 | $114 |
| End Cash | $21 | $5 | $56 | $85 |
| Free Cash Flow | -$47 | -$40 | -$28 | -$29 |